The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; 2 of the 46 sources its claims cite were checked for support.
TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline
Open accessAbstract
Autophagy is a major regulator of the ageing process of the central nervous system and neurodegeneration. Autophagy dysfunction has been implicated in the pathogenesis of Alzheimer’s disease (AD). TRPV1 was reported to regulate autophagy to protect against foam cell formation and reduce the release of inflammatory factors in atherosclerosis. In this study, pharmacological activation of TRPV1 with the TRPV1 agonist capsaicin induced autophagy in a TRPV1-dependent manner in both primary microglia and BV2 cells. TRPV1-mediated autophagy regulated glycolysis and oxidative phosphorylation by controlling the expression of genes required for aerobic glycolysis and mitochondrial respiration in primary microglia. TRPV1 agonist capsaicin decreased amyloid and phosphorylated tau pathology and reversed memory deficits by promoting microglia activation, metabolism, and autophagy in 3xTg mice. These results indicate that TRPV1 was a potential therapeutic target for AD, which suggests that capsaicin should be further assessed as a possible treatment for AD.
Overview
CoChat Summary
TL;DR
In BV2 cells, primary microglia, and 3xTg mice, capsaicin activation of TRPV1 induced microglial autophagy and metabolic reprogramming, promoted Aβ phagocytosis, reduced amyloid/tau pathology, and reversed cognitive deficits. The authors conclude that TRPV1-mediated microglial autophagy is a potential therapeutic target for Alzheimer’s disease.
Key findings
- Capsaicin induced autophagy in microglia in a TRPV1-dependent manner: LC3B-II/I increased dose-dependently at 0.01–20 μM in BV2 cells; 10 μM capsaicin produced autophagosomes, increased mitochondrial length/area and maximal respiratory capacity, and decreased glycolysis/glycolytic capacity. TRPV1−/− mice showed decreased OXPHOS and TCA-cycle gene expression.
- TRPV1 activation promoted autophagic flux and phagocytosis: capsaicin increased mRFP-GFP-LC3 puncta in BV2 cells and primary microglia, while TRPV1−/− attenuated autophagic flux; capsaicin increased FITC-Aβ1-42 uptake (2 μg/ml, 4 h) in BV2 cells and primary microglia, and this was abolished in TRPV1−/− microglia.
- TRPV1 deficiency curtailed microglial energy metabolism via autophagy inhibition: EBSS-stimulated WT microglia increased glycolytic, TCA-cycle, and pentose phosphate pathway metabolites, whereas TRPV1−/− cells showed decreased glucose 6-phosphate, nucleotides, and amino acids; glycolytic genes (Slc2a1, Slc2a3, Hk2, Aldoa, Pgk1, Eno1) and regulators Myc, Irf4, Hif1a were induced in WT but not TRPV1−/− or chloroquine-treated microglia.
- In 7-month-old 3xTg mice, capsaicin (1 mg/kg i.p. daily for 1 month) reversed novel object recognition and Y maze deficits, increased platform crosses in Morris water maze, decreased p-Tau (Ser396)/total tau and 4G8+ amyloid plaque area, and RNA-seq/WGCNA showed improved OXPHOS, mitochondrion organization, neuron/synapse function, and decreased apoptosis/oxidative stress; autophagic markers and microglial activation were increased.
Methods
- In vitro: BV2 murine microglial cells and primary microglia from newborn WT or TRPV1−/− mice; capsaicin 10 μM (dose range 0.01–20 μM for LC3) or rapamycin 2 μM; assays included Western blot, transmission electron microscopy, mRFP-GFP-LC3 autophagy flux, Seahorse OCR/ECAR, LC-MS polar metabolite profiling, qPCR, immunofluorescence, and FITC-Aβ1-42 uptake.
- In vivo: 7-month-old male and female littermate WT and 3xTg mice received capsaicin (1 mg/kg, intraperitoneally, once daily for 1 month); behavioral tests 24 h after final injection included novel object recognition, Y maze spontaneous alteration, and Morris water maze; brain tissue was used for Western blot, histology, RNA sequencing, WGCNA, and microglial morphology.
- Statistics: data presented as mean ± SEM; normality tested by Kolmogorov-Smirnov; one-way ANOVA with Tukey’s post hoc, unpaired two-tailed Student’s t test, or Mann-Whitney U test; p < 0.05 considered significant.
Limitations
- Stated: the authors note that capsaicin mechanisms can include TRPV1-independent pathways and that effects of capsaicin on AD need more research in the future.
- Evident: in vivo TRPV1 dependence was not established with TRPV1−/− or antagonist treatment in the 3xTg AD model; sample sizes were small (e.g., n = 3–9 per group), all data are rodent/cell-based with no human validation, and sex was not analyzed despite use of male and female mice.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
0 Valid · 2 Not valid · 32 Not checked · 84 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Microglia of 3xTg mice showed more end-point voxels and longer branch length than WT mice, which indicated a less activated state of microglia (Figures 8A,B) (Bolmont et al., 2008; Baron et al., 2014; Plescher et al., 2018).”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Result > Genome-Wide RNA Sequencing of 3xTg Mice Reveals Treatment with Capsaicin Alleviates Pathological Hallmarks of AD in 3xTg Mice
What the sources say
- Partly supportedcites Bolmont et al., 2008 sourceExperimental — accuracy not yet measured
Our copy of Bolmont et al. (2008) studies APPPS1 mice crossed with Iba-1-GFP (Mice section), not 3xTg mice; searches for '3xTg' and for an end-point/branch-point voxel measure return nothing. What the paper does provide is a partly corresponding result at a different level of specificity: plaque-adjacent microglia had 48% higher average process length than APPPS1− controls, while 'on'-plaque cells had only 27% of control process length (Alterations in fine morphology and process motility), and the paper links symmetrical ramification to the resting state ('Previously resting microglia with symmetrical ramified processes thus first became polarized and, on reaching the plaque, had enlarged somas and reduced ramification', Microglial migration). The 3xTg-versus-WT comparison, the end-point voxel metric, and the conclusion that 3xTg microglia are in a less activated state are therefore not attributable to this source. (LLM, conf=0.70)
- Disputedcites Baron et al., 2014 sourceExperimental — accuracy not yet measured
Our copy never examines 3xTg mice: the Experimental procedures (Mice) lists only C57BL6, CX3CR1+/GFP, APPSw,Ind (J20) and APP/PS1 Tg strains, and every morphometry figure (Figs. 1-4) is drawn from those models. Moreover, the direction of effect is the opposite of what the citing sentence attributes: Results (Microglial morphology is altered in the cortex of APP Tg mice) reports a significant REDUCTION in bifurcations, branches and total branch length in adult APPSw,Ind Tg mice versus age-matched WT and young Tg mice, with coverage volume down ~50%, interpreted as accelerated/dystrophic microglial pathology rather than a 'less activated' state. The paper also uses no 'end-point voxels' metric — the parameters defined in Results (Quantitative analysis of microglial morphology) are total branch length, number of branches/bifurcations, tree area and coverage volume (L-measure). (LLM, conf=0.65)
Checked by a reasoning model — may be wrong.
- Not checked yetcites Plescher et al., 2018 source
A check is scheduled.
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Stimulation of TRPV1−/− cells resulted in a sharp decrease in the amounts of polar metabolites, such as glucose 6-phosphate (Figure 3A).”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Result > TRPV1 Deficiency Curtails Energy Metabolism in Microglia via Autophagy Inhibition
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The expression levels of OXPHOS and tricarboxylic acid (TCA) cycle genes were decreased in the brain of TRPV1−/− mice compared with the WT group (Figures 1I,J).”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Result > TRPV1 Activation Induced Autophagy and Energetic Metabolism in Microglia
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“3xTg mice showed significant impairment of learning and memory ability at 8-months-old compared to age-matched WT mice (Figures 4A–E)”
- Also stated in: § TRPV1 Activation Reversed Learning and Memory Impairment of 3×Tg AD Mice by Improving Autophagy · boosted
“Memory was strongly impaired in 3xTg mice as compared to the WT group (Time in the target quadrant; Figure 4D).”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Result > TRPV1 Activation Reversed Learning and Memory Impairment of 3×Tg AD Mice by Improving Autophagy
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § TRPV1 Activation Reversed Learning and Memory Impairment of 3×Tg AD Mice by Improving Autophagy · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that upon EBSS-stimulation induced autophagy, transcripts of Myc, Irf4, and Hif1a were strongly induced in WT cells but not in TRPV1−/−-deficient or chloroquine-treated microglia (Figures 3B,C).”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Result > TRPV1 Deficiency Curtails Energy Metabolism in Microglia via Autophagy Inhibition
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
71 more claims
Create a free account to see all 118 claims and to verify the 38 references still open.
- It may state two separate claims as one. 24
- Probably not a substantial claim. 27
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Result > Genome-Wide RNA Sequencing of 3xTg Mice Reveals Treatment with Capsaicin Alleviates Pathological Hallmarks of AD in 3xTg Mice
“the colocalization of LC3B/Iba-1 (Figures 9A,B) or LC3B/NeuN (Figures 9C,D) were significantly decreased”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Result > Genome-Wide RNA Sequencing of 3xTg Mice Reveals Treatment with Capsaicin Alleviates Pathological Hallmarks of AD in 3xTg Mice
“(A, C) Representative images showing the colocalization of LC3B/NeuN (A) or LC3B/Iba-1 (C). (B, D) Quantification of colocalization of LC3B/NeuN (B) or LC3B/Iba-1 (D)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Methods > Western Blotting
“| Rabbit monodonal anti-Atg16L1 (D6D5) | Cell Signaling Technology | 4445T | 1:1000 | — |”
§ TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline > Methods > Western Blotting
“| Rabbit monodonal anti-Atg7 (D12B11) | Cell Signaling Technology | 4445T | 1:1000 | — |”
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
A General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684 · cited 2×
“Weighted gene co-expression network analyses (WGCNA) were performed to analyze 3xTg mice brain co-expression networks that were changed after capsaicin treatment (Zhang and Horvath, 2005).”
MethodTriple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Rubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107 · cited 1×
“The abundance of autophagy-related proteins, such as Beclin1, ATG5, and ATG7, declines with age and is exacerbated during AD (Pickford et al., 2008; Lipinski et al., 2010; Rubinsztein et al., 2011; Lucin et al., 2013).”
BackgroundSignals from the lysosome: a control centre for cellular clearance and energy metabolism
Settembre, C., Fraldi, A., Medina, D. L., & Ballabio, A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3565 · Cited by 1,697
Cited by
Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer’s Disease
Baracaldo-Santamaría, D., Avendaño-Lopez, S. S., Ariza-Salamanca, D. F., Rodríguez-Giraldo, M., Calderón‐Ospina, C., González-Reyes, R. E., & Nava-Mesa, M. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109067 · Cited by 93
Beneficial Effects of Capsaicin in Disorders of the Central Nervous System
Pasierski, M., & Szulczyk, B. (2022) · Molecules · doi:10.3390/molecules27082484 · Cited by 84
TRPV1: The key bridge in neuroimmune interactions
Chen, J., Sun, W., Zhu, Y., Zhao, F., Deng, S., Tian, M. M., Wang, Y., & Gong, Y. (2024) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2024.01.008 · Cited by 64
Huang, Q., Wang, Y., Chen, S., & Liang, F. (2023) · Aging and disease · doi:10.14336/ad.2023.0807 · Cited by 62
Sun, C., Gao, X., Sh, S., Wang, S., Shan, Y., Li, L., Xing, C., Guan, H., & Du, H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114550 · Cited by 44
Metadata
- Authors
- Wang, C., Huang, W., Lu, J., Chen, H., & Yu, Z.
- Affiliations
- Shanghai Jiao Tong University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Corresponding author
- Chen, Hongzhuan
- Yu, Zhihua
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2022-01-18
- Volume
- 12
- Pages
- 763866-763866
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC8804218
- OpenAlex
- W4205466844
- Semantic Scholar
- 5a96e5184fbd448863cb84c5f6a30923a8835348
- Cited by
- 56
- References
- 55
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 21 · 2023: 13 · 2022: 7
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82173791, 81773699)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- TRPV1, Alzheimer's disease, capsaicin, microglial activation, aerobic glycolysis, oxidative phosphorylation, amyloid pathology, tau phosphorylation, memory impairment, 3xTg-AD mice, neurodegeneration, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.